Enterprise Value to EBITDA Multiple ratio Analysis of Evaxion Biotech AS - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-0.570
Period Ending - Dec-22
Very Poor EV to EBITDA
-0.177
Growth
-222.55 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23
Very Poor EV to EBITDA
-1.08
EV to EBITDA Analysis of Evaxion Biotech AS
| EV to EBITDA Ratio of EVAX drastically fell by -222.55 % this year. |
| EV to EBITDA Ratio with value of 1.02 was highest in Year Dec-21 in last Five Years. |
| EV to EBITDA Ratio with value of -0.570 was lowest in Year Dec-23 in last Five Years. |
| Latest EV to EBITDA Ratio with value of -0.570 is lower than Average EV to EBITDA of 0.096 in last five years. |
Other EV to EBITDA Related Info of EVAX that may interest you.
Evaxion Biotech AS Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| EVAX | 3.72 | 3.83 | 2.87 % | Biotechnology |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..
EV to EBITDA Related Ratios
| EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Enterprise Value to EBITDA Multiple of Evaxion Biotech AS
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
|---|---|---|---|---|---|---|---|
| EV to EBITDA | -0.570 | -0.177 | 1.02 | -0.0129 | 0.222 | -1.52 | 0 |
| Change | -222.55 % | -117.34 % | 8002.63 % | -105.80 % | 114.62 % |
FY Chart of Enterprise Value to EBITDA Multiple of Evaxion Biotech AS
Note : All Data Generated at the End of Trading Hours (EOD Data)